Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+155.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
+155.3%/yr
Quarterly compound
Percentile
P90
Near historical high
vs 3Y Ago
16.6x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202536.89%
Q3 202518.94%
Q2 20251.10%
Q1 20254.32%
Q4 2024-10.09%
Q3 2024-6.91%
Q2 202458.13%
Q1 2024216.38%
Q4 2023-19.57%
Q3 2023-18.37%
Q2 2023-12.90%
Q1 2023-5.77%
Q4 20222.22%
Q3 2022-11.87%
Q2 2022-12.31%
Q1 2022-8.90%
Q4 2021-8.83%
Q3 2021-0.06%
Q2 2021-5.00%
Q1 202139.16%
Q4 2020-7.38%
Q3 2020159.91%
Q2 20200.00%
Q1 2020-100.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q1 20190.00%
Q4 2017-1.97%
Q3 2017-5.89%
Q2 2017-2.45%
Q1 20170.21%
Q4 20160.22%
Q3 2016-1.05%
Q2 201612.42%
Q1 20161.46%
Q4 2015-5.08%
Q3 20150.07%
Q2 20158.33%
Q1 2015-0.15%